Literature DB >> 22398617

Debunking the myth that whole-genome sequencing infringes thousands of gene patents.

Christopher M Holman1.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22398617     DOI: 10.1038/nbt.2146

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  6 in total

1.  Incyte comes of age with JAK inhibitor approval.

Authors:  Nuala Moran
Journal:  Nat Biotechnol       Date:  2012-01-09       Impact factor: 54.908

2.  Intellectual property. Enhanced: intellectual property landscape of the human genome.

Authors:  Kyle Jensen; Fiona Murray
Journal:  Science       Date:  2005-10-14       Impact factor: 47.728

3.  Genetics. Trends in human gene patent litigation.

Authors:  Christopher M Holman
Journal:  Science       Date:  2008-10-10       Impact factor: 47.728

4.  Legal uncertainty in the area of genetic diagnostic testing.

Authors:  Isabelle Huys; Nele Berthels; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Biotechnol       Date:  2009-10       Impact factor: 54.908

Review 5.  Patents in genomics and human genetics.

Authors:  Robert Cook-Deegan; Christopher Heaney
Journal:  Annu Rev Genomics Hum Genet       Date:  2010       Impact factor: 8.929

6.  Metastasizing patent claims on BRCA1.

Authors:  Thomas B Kepler; Colin Crossman; Robert Cook-Deegan
Journal:  Genomics       Date:  2010-03-10       Impact factor: 5.736

  6 in total
  17 in total

Review 1.  The fate and future of patents on human genes and genetic diagnostic methods.

Authors:  Isabelle Huys; Gert Matthijs; Geertrui Van Overwalle
Journal:  Nat Rev Genet       Date:  2012-05-18       Impact factor: 53.242

2.  DREAMing of a patent-free human genome for clinical sequencing.

Authors:  Kevin J McKernan; Jessica Spangler; Yvonne Helbert; Lei Zhang; Vasisht Tadigotla
Journal:  Nat Biotechnol       Date:  2013-10       Impact factor: 54.908

3.  Advances in DNA sequencing lead to patent disputes.

Authors:  Christopher M Holman
Journal:  Nat Biotechnol       Date:  2012-11       Impact factor: 54.908

4.  Patent landscaping for life sciences innovation: toward consistent and transparent practices.

Authors:  Tania Bubela; E Richard Gold; Gregory D Graff; Daniel R Cahoy; Dianne Nicol; David Castle
Journal:  Nat Biotechnol       Date:  2013-03       Impact factor: 54.908

5.  Synthetic biology, patenting, health and global justice.

Authors:  Henk van den Belt
Journal:  Syst Synth Biol       Date:  2012-10-30

6.  Gene patents in the US--focusing on what really matters.

Authors:  Allison W Dobson; James P Evans
Journal:  Genome Biol       Date:  2012-06-29       Impact factor: 13.583

7.  Patents and genome-wide DNA sequence analysis: is it safe to go into the human genome?

Authors:  Robert Cook-Deegan; Subhashini Chandrasekharan
Journal:  J Law Med Ethics       Date:  2014       Impact factor: 1.718

8.  Harm, hype and evidence: ELSI research and policy guidance.

Authors:  Timothy Caulfield; Subhashini Chandrasekharan; Yann Joly; Robert Cook-Deegan
Journal:  Genome Med       Date:  2013-03-26       Impact factor: 11.117

9.  Gene patents and personalized cancer care: impact of the Myriad case on clinical oncology.

Authors:  Kenneth Offit; Angela Bradbury; Courtney Storm; Jon F Merz; Kevin E Noonan; Rebecca Spence
Journal:  J Clin Oncol       Date:  2013-06-13       Impact factor: 44.544

10.  Translating genomic information into clinical medicine: lung cancer as a paradigm.

Authors:  Mia A Levy; Christine M Lovly; William Pao
Journal:  Genome Res       Date:  2012-09-27       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.